Kirsa Skov-Jeppesen
Overview
Explore the profile of Kirsa Skov-Jeppesen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jensen M, Gasbjerg L, Skov-Jeppesen K, Jacobsen J, Poulsen S, Zhou C, et al.
J Clin Endocrinol Metab
. 2024 Aug;
110(3):715-729.
PMID: 39172542
Context: About 30% of patients with active acromegaly experience paradoxically increased growth hormone (GH) secretion during the diagnostic oral glucose tolerance test (OGTT). Endogenous glucose-dependent insulinotropic polypeptide (GIP) is implicated...
2.
Skov-Jeppesen K, Christiansen C, Hansen L, Windelov J, Hedback N, Gasbjerg L, et al.
J Clin Endocrinol Metab
. 2024 Jan;
109(7):1773-1780.
PMID: 38217866
Context: Individuals with type 2 diabetes (T2D) have an increased risk of bone fractures despite normal or increased bone mineral density. The underlying causes are not well understood but may...
3.
Gether L, Storgaard H, Kezic S, Jakasa I, Hartmann B, Skov-Jeppesen K, et al.
Allergy
. 2023 Feb;
78(7):1964-1979.
PMID: 36824052
Introduction: Topical corticosteroids (TCS), used to treat atopic dermatitis (AD), have been associated with type 2 diabetes and osteoporosis in epidemiological studies, possibly explained by systemic absorption. Objectives: We examined...
4.
Dalsgaard N, Gasbjerg L, Helsted M, Hansen L, Hansen N, Skov-Jeppesen K, et al.
Bone
. 2023 Feb;
170:116687.
PMID: 36754130
Aims: The alpha-glucosidase inhibitor acarbose is an antidiabetic drug delaying assimilation of carbohydrates and, thus, increasing the amount of carbohydrates in the distal parts of the intestines, which in turn...
5.
Krogh L, Henriksen K, Stensen S, Skov-Jeppesen K, Bergmann N, Storling J, et al.
Eur J Endocrinol
. 2023 Jan;
188(1).
PMID: 36651162
Objective: The gut hormone glucose-dependent insulinotropic polypeptide (GIP) is an important regulator of glucose and bone metabolism. In rodents, the naturally occurring GIP variant, GIP(1-30)NH2, has shown similar effects as...
6.
Heimburger S, Hoe B, Nielsen C, Bergman N, Skov-Jeppesen K, Hartmann B, et al.
J Clin Endocrinol Metab
. 2022 Sep;
107(12):3261-3274.
PMID: 36111559
Context: Glucose-dependent insulinotropic polypeptide (GIP) has been proposed to exert insulin-independent effects on lipid and bone metabolism. Objective: We investigated the effects of a 6-day subcutaneous GIP infusion on circulating...
7.
Hagemann C, Jensen M, Holm S, Gasbjerg L, Byberg S, Skov-Jeppesen K, et al.
Cell Rep Med
. 2022 May;
3(4):100582.
PMID: 35492241
The gastric hormone ghrelin stimulates food intake and increases plasma glucose through activation of the growth hormone secretagogue receptor (GHSR). Liver-expressed antimicrobial peptide 2 (LEAP2) has been proposed to inhibit...
8.
Gabe M, Skov-Jeppesen K, Gasbjerg L, Schiellerup S, Martinussen C, Gadgaard S, et al.
Pharmacol Res
. 2022 Jan;
176:106058.
PMID: 34995796
The intestinal hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-2 (GLP-2) are key regulators of postprandial bone turnover in humans. We hypothesized that GIP and GLP-2 co-administration would provide stronger...
9.
Abildgaard J, Johansen M, Skov-Jeppesen K, Andersen L, Karstoft K, Hansen K, et al.
Med Sci Sports Exerc
. 2021 Aug;
54(1):38-46.
PMID: 34431828
Introduction/purpose: The increased risk of fractures with type 2 diabetes (T2D) is suggested to be caused by decreased bone turnover. Current international guidelines recommend lifestyle modifications, including exercise, as first-line...
10.
Skov-Jeppesen K, Veedfald S, Madsbad S, Holst J, Rosenkilde M, Hartmann B
Bone
. 2021 Jun;
152:116065.
PMID: 34153529
Background: Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-2 (GLP-2) are gut hormones secreted in response to food ingestion, and they have been suggested to regulate bone turnover. In humans, exogenous...